大豐港(08310.HK)預期一季度虧損擴大至約2270萬港元
格隆匯5月5日丨大豐港(08310.HK)發佈公吿,公司預期於截至2022年3月31日止三個月將錄得虧損約2270萬港元,而2021年同期錄得虧損約1270萬港元。這主要是由於(i)收益較2021年同期減少約79.2%,此歸因於奧密克戎變異病毒引發第五波社區爆發以及2022年初香港感染個案驟增,對跨境運輸及物流造成重大不利影響,當中香港業務佔集團貿易分部中電子及其他產品的98%以上;及(ii)人民幣兑美元升值對我們的貿易業務分部造成不利影響,因為進出口貿易主要以美元計價,人民幣升值嚴重影響貿易交易量,進而影響集團的貿易業務環境。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.